Adient (NYSE:ADNT) Upgraded at BNP Paribas

Adient (NYSE:ADNT) was upgraded by equities research analysts at BNP Paribas from an “underperform” rating to a “neutral” rating in a research note issued to investors on Monday, Briefing.com reports. The firm currently has a $26.00 price objective on the stock. BNP Paribas’ price objective suggests a potential upside of 5.22% from the company’s previous close.

Other equities analysts have also recently issued research reports about the company. JPMorgan Chase & Co. lowered their price target on Adient from $40.00 to $37.00 and set a “neutral” rating for the company in a report on Monday, April 22nd. Morgan Stanley lowered their target price on Adient from $35.00 to $32.00 and set an “underweight” rating for the company in a report on Friday, May 10th. Barclays lowered their target price on Adient from $37.00 to $34.00 and set an “equal weight” rating for the company in a report on Tuesday, May 7th. Bank of America lowered their target price on Adient from $50.00 to $46.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Adient from $32.00 to $30.00 and set a “hold” rating on the stock in a research report on Monday, May 6th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Adient presently has a consensus rating of “Hold” and an average target price of $37.67.

Adient Price Performance

Adient stock opened at $24.71 on Monday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.91 and a current ratio of 1.13. Adient has a 52 week low of $24.22 and a 52 week high of $46.51. The stock has a market capitalization of $2.22 billion, a P/E ratio of 15.16, a price-to-earnings-growth ratio of 0.33 and a beta of 2.31. The stock has a fifty day moving average of $27.74 and a 200-day moving average of $31.62.

Adient (NYSE:ADNT) last posted its quarterly earnings results on Friday, May 3rd. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.15. Adient had a return on equity of 8.72% and a net margin of 1.04%. The company had revenue of $3.75 billion during the quarter, compared to analysts’ expectations of $3.80 billion. During the same quarter in the previous year, the firm earned $0.32 EPS. Adient’s revenue was down 4.1% on a year-over-year basis. On average, sell-side analysts expect that Adient will post 2.26 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Adient news, Director Peter Carlin sold 4,207 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $28.90, for a total value of $121,582.30. Following the transaction, the director now owns 28,352 shares in the company, valued at $819,372.80. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Institutional Trading of Adient

A number of institutional investors and hedge funds have recently modified their holdings of the business. Boston Partners increased its position in shares of Adient by 12.2% during the first quarter. Boston Partners now owns 19,661 shares of the company’s stock valued at $647,000 after acquiring an additional 2,139 shares during the last quarter. Janus Henderson Group PLC increased its position in Adient by 48.5% in the first quarter. Janus Henderson Group PLC now owns 697,303 shares of the company’s stock worth $22,955,000 after buying an additional 227,810 shares during the last quarter. Bayesian Capital Management LP purchased a new stake in Adient in the first quarter worth $316,000. Price T Rowe Associates Inc. MD increased its position in Adient by 5.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 56,647 shares of the company’s stock worth $1,865,000 after buying an additional 2,687 shares during the last quarter. Finally, Magnetar Financial LLC purchased a new stake in Adient in the first quarter worth $2,746,000. 92.44% of the stock is owned by hedge funds and other institutional investors.

About Adient

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.